Most safety concerns with BPC-157 relate to product quality rather than inherent peptide properties
We know that macrocytosis is a very, very late stage of B12 deficiency and that severely deficient patients may not present with this sign, the administration of folic acid also masks macrocytosis by normalising the size of the blood cells
The labeled ladder is 2.5, 5, 7.5, 10, 12.5, and 15 mg once weekly, with each escalation step held for at least four weeks
[1] [3] The injection bypasses the gastrointestinal tract entirely, making it particularly effective for patients with absorption problems such as pernicious anaemia or those who have undergone gastric surgery
BPC 157 Side Effects: What to Know Though BPC 157 is often touted for its potential benefits, it is crucial to discuss what side effects may arise from its use
What it is